The medicinal use of realgar (As4S4) and its recent development as an anticancer agent

Journal of Ethnopharmacology

Volumn 135, Issue 3, 2011, Pages 595-602

  Wu, Jinzhu ^a   Shao, Yanbin ^a   Liu, Jialiang ^b   Chen, Gang ^a   Ho, Paul C ^c  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b MuDanJiang HengYuan Pharmaceutical Co Ltd   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Acute promyelocytic leukemia; As4S4; Nanoparticle; Quantum dot; Realgar

Indexed keywords

ANTILEUKEMIC AGENT; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; IMATINIB; ORGANOARSENIC DERIVATIVE; REALGAR; UNCLASSIFIED DRUG; ARSENIC; ARSENIC DISULFIDE; OXIDE; SULFIDE;

ABDOMINAL PAIN; ANTIQUITY; CARBUNCLE; CHINESE MEDICINE; CHRONIC MYELOID LEUKEMIA; CIVILIZATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG TOXICITY AND INTOXICATION; FURUNCULOSIS; GASTROINTESTINAL SYMPTOM; HUMAN; INSECT BITE; LUMPY SKIN DISEASE; MALARIA; MELANOMA; NONHUMAN; PARTICLE SIZE; PROMYELOCYTIC LEUKEMIA; QT PROLONGATION; REVIEW; SEIZURE; SIDE EFFECT; SKIN DISEASE; SKIN TUMOR; SNAKEBITE; HISTORY; LEUKEMIA; TRADITIONAL MEDICINE;

ANTINEOPLASTIC AGENTS; ARSENIC; ARSENICALS; HISTORY, 16TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HISTORY, MEDIEVAL; HUMANS; LEUKEMIA; MEDICINE, TRADITIONAL; OXIDES; SULFIDES;

EID: 79957510043     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2011.03.071     Document Type: Review

References (65)

1. H.V. Aposhian, B. Zheng, M.M. Aposhian, X.C. Le, M.E. Cebrian, and W. Cullen DMPS-arsenic challenge test II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine Toxicology and Applied Pharmacology 165 2000 74 83 (Pubitemid 30346462)
2. 4 nanoparticles Materials Letters 63 2009 1542 1544
3. 3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RAR alpha/PML proteins Blood 88 1996 1052 1061 (Pubitemid 26333331)
4. S.M. Cohen, L.L. Arnold, M. Eldan, A.S. Lewis, and B.D. Beck Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment Critical Reviews in Toxicology 36 2006 99 133
5. W.R. Cullen, B.C. McBride, and J. Reglinski The reduction of trimethylarsine oxide to trimethylarsine by thiols: a mechanistic model for the biological reduction of arsenicals Journal of Inorganic Biochemistry 21 1984 45 60 (Pubitemid 14123695)
6. L.M. Del Razo, M. Stybo, W.R. Cullen, and D.J. Thomas Determination of trivalent methylated arsenicals in biological matrices Toxicology and Applied Pharmacology 174 2001 282 293 (Pubitemid 32747839)
7. Y. Deng, H.B. Xu, K.X. Huang, X.L. Yang, C.S. Xie, and J. Wu Size effects of realgar particles on apoptosis in a human umbilical vein endothelial cell line: ECV-304 Pharmaceutical Research 44 2001 513 518 (Pubitemid 34019154)
8. G. Gan, J. Sun, J.Y. Wang, and Y. Wang Analysis of 27 cases on serious adverse drug reaction induced by arsenic trioxide Chinese Journal of Pharmacovigilance (in Chinese) 05 2008 286 290
9. H.R. Hansen, A. Raab, M. Jaspar, B.F. Milne, and J. Feldmann Sulfur-containing arsenical mistaken for dimethylarsinous acid (DMA(III)) and identified as a natural metabolite in urine: major implications for studies on arsenic metabolism and toxicity Chemical Research in Toxicology 17 2004 1086 1091 (Pubitemid 39108676)
10. S.L. Huang, A.X. Guo, Y. Xiang, X.B. Wang, H.J. Ling, and J. Fu Clinical study on the treatment of acute promyelocytic leukemia with Composite Indigo Naturalis tablets Chinese Journal of Hematology (in Chinese) 16 1995 26 28
11. D.M. Jolliffe A history of the use of arsenicals in man Journal of the Royal Society of Medicine 86 1993 287 289 (Pubitemid 23142231)
12. I. Koch, S. Steven, V.W.M. Lai, A. Owen, K.J. Reimer, and W.R. Cullen Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pills Toxicology and Applied Pharmacology 222 2007 357 364 (Pubitemid 47198273)
13. S.Y. Kwan, S.K. Tsui, and T.O. Man Release of soluble arsenic from realgar in simulated gastric juice Analytical Letters 34 2001 1431 1436 (Pubitemid 32730829)
14. P.P. Li Could we use clinical benefit to evaluate the effects of Chinese medicine on the treatment of cancer? Chinese Journal of Integrative Medicine 16 2010 9 10
15. J. Liu, Y. Lu, Q. Wu, R.A. Goyer, and M.P. Waalkes Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite Journal of Pharmacology and Experimental Therapeutics 326 2008 363 368
16. J. Liu, S.X. Liang, Y.F. Lu, J.W. Miao, and Q. Wu Shi, J. S. Realgar and realgar-containing Liu-Shen-Wan are less actutely toxic than arsneite and arsenate Journal of Ethnopharmacology 134 2011 26 31
17. R. Liu, D.M. Pu, Y. Liu, Y.X. Cheng, L. Yin, and T. Li Induction of SiHa cells apoptosis by nanometer realgar suspension and its mechanism Journal of Huazhong University Science and Technology - Medical Sciences 28 2008 317 321
18. D.P. Lu, J.C. Qiu, and S.S. Chen Oral administration of realgar in the treatment of acute promyelocytic leukemia (AML-M3), 66 Cases Chinese Journal of Laboratory Diagnosis (in Chinese) 6 1998 319 320
19. D.P. Lu, J.Y. Qiu, B. Jiang, Q. Wang, K.Y. Liu, and Y.R. Liu Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report Blood 99 2002 3136 3143 (Pubitemid 34525290)
20. D.P. Lu, and Q. Wang Current study of APL treatment in China International Journal of Hematology 76 2002 316 318
21. Y.F. Lu, J.W. Yan, Q. Wu, J.Z. Shi, J. Liu, and J.S. Shi Realgar- and realgar-containing An-Gong-Niu-Huang Wan (AGNH) is much less acutely toxic than sodium arsenite and mercutic chloride Chemico-Biological Interactions 189 2011 134 140
22. Lu, Y.F.; Wu, Q.; Yan, J.W.; Shi, J.Z.; Liu, J.; Shi, J.S. Realgar, cinnabar and An-Gong-Niu-Huang Wan (AGNH) are much less chronically nephrotoxic than common arsenicals and mercurial. Experimental Biology and Medicine (in press).
23. L.Y. Luo, J. Huang, B.D. Guo, T.L. Zhang, and K. Wang Induction of human promyelocytic into monocytes by arsenic leukemia HL-60 cell differentiation sulphide: involvement of serine/threonine protein phosphatases Leukemia Research 30 2006 1399 1405 (Pubitemid 44316859)
24. 4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia Proceedings of the National Academy of Sciences of the United States of America 107 2010 21683 21688
25. M.J. McCabe, K.P. Singh, S.A. Reddy, B. Chelladurai, J.G. Pounds, and J.J. Reiners Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment and cell cycle phase Journal of Pharmacology and Experimental Therapeutics 295 2000 724 733
26. W.H. Miller Jr.; H.M Schipper, J.S. Lee, J. Singer, and S. Waxman Mechanisms of action of arsenic trioxide Cancer Research 62 2002 3893 3903 (Pubitemid 34792653)
27. L.S. Qian, Y.Z. Zhao, and The Cooperation Group of Phase II Clinical Trial of Compound Huangdai Tablet Phase II clinical trial of compound Huangdai tablet in newly diagnosed acute promyelocytic leukemia Chinese Journal of Hematology 27 2006 801 804
28. X.Y. Qin, B. Jiang, G.X. Li, and D.P. Lu Chronic hepatic damage in acute promyelocytic leukemia patients treated with tetra-arsenic tetra-sulfide Chinese Journal of Hematology (in Chinese) 04 2006 259 263
29. F.B. Qu, C.M. Lu, H. Wang, and C.L. Qu Use of Awei HuaPi Gao in the relief of ovarian cancer pain Chinese Journal of Medicine (in Chinese) 2 2004 30
30. 4) on the corrected QT interval in the treatment of acute promyelocytic leukemia Chinese Journal of Hematology (in Chinese) 06 2004 41 43
31. X.C. Shen, T. Jin, J. Xie, H. Liang, and Y. Yan Studies on the biomimetic membrane interaction between liposome and realgar nanoparticles Science in China Series B-Chemistry 52 2009 1512 1518
32. Shen, X.C.; Liang, H.; Chen, Y.; Guo, Y.F.; Wei, J.; 2005. China Patent: ZL200510020488.5 (in Chinese).
33. 3) in the treatment of acute promyelocytic leukemia (APL) 2. Clinical efficacy and pharmacokinetics in relapse patients Blood 89 1997 3354 3360
34. H.D. Sun, L. Ma, X.C. Hu, and T.D. Zhang Treatment of acute promyelocytic leukemia with AiLing I in 32 cases Chinese Journal Integrative Traditional and West Medicine (in Chinese) 03 1992 170 171
35. P.M. Tate, B.J. Patgiri, and P.K. Prajapati Pharmaceutical standardization of naga bhasma An International Quarterly Journal of Research in Ayunveda 30 2009 300 309
36. X. Thomas, and J. Troncy Arsenic: a beneficial therapeutic poison - a historical overview Adler Museum Bulletin 35 2009 3 13
37. L. Wang, G.B. Zhou, P. Liu, J.H. Song, Y. Liang, and X.J. Yan Dissection of mechanisms of Chinese medicinal formula realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia Proceedings of National Academy of Sciences of the United States of America 105 2008 4826 4831 (Pubitemid 351753831)
38. J.Z. Wang, M. Lin, T.Y. Zhang, Y.L. Yan, P.C. Ho, and Q.H. Xu Arsenic (II) sulfide quantum dots prepared by a wet process from its bulk Journal of the American Chemical Society 130 2008 11596 11597
39. J.Z. Wang, M. Lin, Y.L. Yan, Z. Wang, P.C. Ho, and K.P. Loh CdSe/AsS core-shell quantum dots: preparation and two-photon fluorescence Journal of American Chemical Society 131 2009 11300 11301
40. J.Z. Wang, K.P. Loh, Z. Wang, Y.L. Yan, Y.L. Zhong, and Q.H. Xu Fluorescent nanogel of arsenic sulfide nanoclusters Angewandte Chemie International Edition 48 2009 6282 6285
41. M.C. Wang, L.H. Yang, S.X. Liu, and X.M. Li Study on realgar induced apoptosis of multiple myeloma cells and clinical application Shaanxi Medical Journal (in Chinese) 31 2002 38 39
42. N. Wang, L.W. Wang, B.D. Gou, and T.L. Zhang Preparation of realgar nanoparticle suspension and its inhibition effect on the proliferation of human myelocytic leukaemia HL-60 cells Journal of Dispersion Science and Technology 30 2009 237 240
43. N. Wang, L.W. Wang, B.D. Gou, T.L. Zhang, and K. Wang Realgar-induced differentiation is associated with MAPK pathways in HL-60 cells Cell Biology International 32 2008 1497 1505
44. X.B. Wang, H.Y. Gao, B.L. Hou, J. Huang, R.G. Xi, and L.J. Wu Nanoparticle realgar powders induce apoptosis in U973 cells through caspase MAPK and mitochondrial pathways Archives Pharmaceutical Research 30 2007 653 658
45. X.B. Wang, R.G. Xi, Z.L. Li, R.M. Ren, and S.L. Huang Preparation of nanoparticle realgar powders Pharmaceutical Journal of Chinese People's Liberation Army (in Chinese) 18 2002 129 133
46. J.Z. Wu, and P.C. Ho Evaluation of the in vitro activity and in vivo bio-availability of realgar nanoparticles prepared by cryo-grinding European Journal of Pharmaceutical Sciences 29 2006 266 271
47. J.Z. Wu, and P.C. Ho Comparing the relative oxidative dna damage caused by various arsenic species by quantifying urinary levels of 8-hydroxy-2′- deoxyguanosine with isotope-dilution liquid chromatography/mass spectrometry Pharmaceutical Research 26 2009 1525 1533
48. X.H. Wu, D.H. Sun, Z.X. Zhuang, X.R. Wang, H.F. Gong, and J.X. Hong Aanlysis and leaching characteristics of mercury and arsenic in Chinese medicinal material Analytical Chimica Acta 453 2002 311 323
49. Y. Xiang, S.L. Huang, A.X. Guo, Y.H. Bai, F.R. Han, and M.Q. Ji Clinical study on the treatment of acute promyelocytic leukemia with composite indigo naturalis tablets, 60 cases Medical Journal Chinese People's Liberation Army (in Chinese) 01 1995 26 28
50. Y. Xiang, S.L. Huang, A.X. Guo, A.H. Wei, L. Zhang, and S.J. Sun The influence on long-term survey of the patients with acute promyelocytic leukemia treated with compound huangdai tablets and chemotherapy Chinese Journal of Clinical Hematology 16 2007 204 206
51. X.Z. Yang, J.B. Hu, S.F. Lin, S.Q. Liu, R.Q. Chen, and S.J. Song Clinical study on the treatment of Leukemia with BaiXueNing I composite Journal of Chinese Hematology (in Chinese) 01 1999 20 21
52. H.Q. Ye, L. Gan, X.L. Yang, and H.B. Xu Membrane toxicity accounts for apoptosis induced by realgar nanoparticles in promyelocytic leukemia HL-60 cells Biological Trace Element Research 103 2005 117 132 (Pubitemid 40626975)
53. 4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein Blood 104 2004 246B 247B
54. C. Zhang Effects of realgar on the proliferation of hepatoma cell line BEL-7402 Chinese Hepatology (in Chinese) 9 2004 112 113
55. P. Zhang, S.Y. Wang, L.H. Hu, F.D. Shi, F.Q. Qiu, and L.J. Hong Arsenic trioxide injection in the treatment of 72 patients with acute promyelocytic leukemia Chinese Journal of Hematology (in Chinese) 02 1996 58 60
56. Q.H. Zhang, J.H. Mao, P. Liu, Q.H. Huang, J. Lu, and Y.Y. Xie A systems biology understanding of the synergistic effects of arsenic sulfide and Imatibib in BCR/ABL-associated leukemia Proceedings of National Academy of Sciences of the United States of America 106 2009 3378 3383
57. T.D. Zhang, and F.X. Rong Treatment of acute myeloid leukemia with AiLing I injection HeiLongJiang Medical Journal (in Chinese) 04 1973 9 11
58. T.D. Zhang, P.F. Zhang, S.R. Wang, and T.Y. Han Preliminary clinical study on the treatment of leukemia with AiLing injection in 6 cases HeiLongJiang Medical Journal (in Chinese) 03 1973 66 67
59. W. Zhang, B.Y. Yu, J.P. Kou, and J.R. Wang Studies on the correlation between toxicity and activities of realgar Chinese Journal of Natural Medicine 2 2004 123 125 (Pubitemid 38745221)
60. Q.H. Zhao, Y. Zhang, Y. Liu, H.L. Wang, Y.Y. Shen, and W.J. Yang Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery Medical Oncology 27 2010 203 212
61. J.F. Zheng, and A.X. Zhou Preliminary report of 10 cases in the treatment of acute leukemia with KangBai Dan Journal of Traditional Chinese Medicine (in Chinese) 06 1983 37 38
62. L. Zhong, F.Y. Chen, J.Y. Han, N.X. Shao, and R.R. OuYang Study of Expression of PML Gene and PML Protein in Leukemia Cells Journal of ShangHai Second Milinary Medical University (in Chinese) 02 2001 106 109 133
63. A.X. Zhou, Z.W. Chen, J.M. Yang, T.E. Wang, L. Yang, Q. Wang, R. Ma, F. Liu, J.F. Zheng, C.S. Deng, B.S. Yao, Z.F. Wang, N.P. Hu, and Z.X. Wang Clinical Study on Chronic Myelogenous Leukemia Treated with QingHuang San in 86 Cases 1997 World Integrative Medicine Congress
64. A.X. Zhou, B.S. Yao, and J.F. Deng Therapeutic efficacy of QingHuang San in the treatment of Chronic myeloid leukemia, 25 cases Chinese Journal Integrative Medicine (in Chinese) 01 1981 16 18
65. M.C. Zou, and H.C. Ni Analysis of adverse reactions to detoxicating tablets (pills) of cow-bezoar in 40 cases World Clinical Drugs (in Chinese) 01 2007 16